MDCX Medicus Pharma Ltd.
$0.16▲ +0.74%
Healthcare
Other
After hours
$0.16▼ -3.32%
Sep 11, 7:58 PM ET
Volume 3.41M
Avg Volume (10D) 16.43M
Key Metrics & Fundamentals
Market Cap
$10.27M
P/E Ratio
–
Div Yield
–%
52W Range
0.15 - 3.05
% vs 50 MA
-46.68%
% vs 200 MA
-78.06%
RSI-14
27.0
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.80
Free Cash Flow
-$6.98M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$11.48M
COGS
–
Operating Exp
$11.48M
Operating Income
-$11.48M
EBIT
-$11.48M
Pretax Income
-$11.68M
Net Income
-$11.62M
EPS (Diluted)
-0.21
Price & Volume History
Loading chart…
Recent News

Medicus Pharma CEO on SkinJect and Pfizer partnership – ICYMI
Proactive · Sep 12, 2026 2:32 PM

Medicus Pharma secures Pfizer ADC deal, advances SkinJect and precision oncology strategy
Proactive · Sep 10, 2026 3:58 PM

Medicus Pharma Identifies 200 µg SkinJect Patch as Lead Development Dose After Phase 2 Study
InvestorsHub · Sep 10, 2026 2:38 PM

Medicus Pharma reports positive Phase 2 data for SkinJect in skin cancer treatment
Proactive · Sep 10, 2026 1:45 PM

Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose
GlobeNewswire · Sep 10, 2026 11:30 AM

Dow closes sharply lower as oil surge fuels inflation fears
Proactive · Sep 8, 2026 2:10 PM

Medicus Pharma reorients around new cancer drug candidate, sharpens focus for other programs
Proactive · Sep 8, 2026 1:34 PM

Medicus Pharma Prioritises CD228V Oncology Programme in Development Strategy
InvestorsHub · Sep 8, 2026 12:53 PM

Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company
GlobeNewswire · Sep 8, 2026 11:30 AM
BC-Most Active Stocks
Associated Press · Sep 3, 2026 2:30 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MDCX's money flow as a full page
Social Sentiment
No Reddit posts found for MDCX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.